Cannara Biotech Inc (LOVE.V)
0.81
+0.01
(+1.25%)
CAD |
TSXV |
May 17, 16:00
Cannara Biotech Enterprise Value: 118.46M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 118.46M |
| May 16, 2024 | 117.56M |
| May 15, 2024 | 114.86M |
| May 14, 2024 | 114.86M |
| May 13, 2024 | 118.46M |
| May 10, 2024 | 115.76M |
| May 09, 2024 | 115.76M |
| May 08, 2024 | 112.16M |
| May 07, 2024 | 113.96M |
| May 06, 2024 | 112.16M |
| May 03, 2024 | 113.96M |
| May 02, 2024 | 117.56M |
| May 01, 2024 | 120.26M |
| April 30, 2024 | 115.76M |
| April 29, 2024 | 116.66M |
| April 26, 2024 | 121.16M |
| April 25, 2024 | 122.07M |
| April 24, 2024 | 121.16M |
| April 23, 2024 | 120.26M |
| April 22, 2024 | 118.46M |
| April 19, 2024 | 119.36M |
| April 18, 2024 | 123.87M |
| April 17, 2024 | 123.87M |
| April 16, 2024 | 122.97M |
| April 15, 2024 | 126.57M |
| Date | Value |
|---|---|
| April 12, 2024 | 127.47M |
| April 11, 2024 | 129.27M |
| April 10, 2024 | 130.17M |
| April 09, 2024 | 123.87M |
| April 08, 2024 | 121.16M |
| April 05, 2024 | 123.87M |
| April 04, 2024 | 125.67M |
| April 03, 2024 | 126.57M |
| April 02, 2024 | 125.67M |
| April 01, 2024 | 127.47M |
| March 28, 2024 | 129.27M |
| March 27, 2024 | 127.47M |
| March 26, 2024 | 129.27M |
| March 25, 2024 | 129.27M |
| March 22, 2024 | 131.97M |
| March 21, 2024 | 131.97M |
| March 20, 2024 | 131.97M |
| March 19, 2024 | 131.97M |
| March 18, 2024 | 131.07M |
| March 15, 2024 | 131.07M |
| March 14, 2024 | 130.17M |
| March 13, 2024 | 129.27M |
| March 12, 2024 | 132.87M |
| March 11, 2024 | 132.87M |
| March 08, 2024 | 131.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
104.07M
Minimum
May 26 2021
163.87M
Maximum
Jul 19 2021
128.28M
Average
126.22M
Median
Oct 10 2023
Enterprise Value Benchmarks
| Biocure Technology Inc | 1.448M |
| Core One Labs Inc | 8.808M |
| Nova Mentis Life Science Corp | 2.183M |
| Nanosphere Health Sciences Inc | 0.2445M |
| Lobe Sciences Ltd | 3.658M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.447M |
| Revenue (Quarterly) | 19.68M |
| Total Expenses (Quarterly) | 21.64M |
| EPS Diluted (Quarterly) | -0.04 |
| Gross Profit Margin (Quarterly) | 21.04% |
| Profit Margin (Quarterly) | -17.51% |
| Earnings Yield | 7.41% |
| Operating Earnings Yield | 16.04% |
| Normalized Earnings Yield | 7.436 |